David E. Comings

Last updated
David Comings
Born (1935-03-08) March 8, 1935 (age 89)
NationalityAmerican
Education University of Illinois
Feinberg School of Medicine
Spouse
Sally
(m. 2008)
[1]
AwardsFellow of the American Society for Clinical Investigation (1968)
Scientific career
Institutions City of Hope National Medical Center

David E. Comings (born March 8, 1935) [2] [3] is an American medical geneticist and former chief of genetics at the City of Hope National Medical Center in Duarte, California, a position he held from 1966 until his 2002 retirement. [4] [5] [3] He has served as the president of the American Society of Human Genetics (1988) and the editor-in-chief of The American Journal of Human Genetics (1979–86). [3] He has been a fellow of the American Society for Clinical Investigation since 1968. [6] He is known for his research on the genetics of Tourette's syndrome, which he began studying in 1980 with his wife, Brenda Comings. [7] [5] He has also studied the role of genetics in nicotine addiction [8] and alcoholism. [9] Although Dr. Comings retired in 2002 (and closed his laboratory at the end of 2003), he remained active in the field through 2016. He currently directs 'The Comings Foundation': a private foundation (www.TheComingsFoundation.org) devoted to combatting climate change and advancing the Medical Sciences.

Books

Related Research Articles

<span class="mw-page-title-main">Tourette syndrome</span> Neurodevelopmental disorder involving motor and vocal tics

Tourette syndrome or Tourette's syndrome is a common neurodevelopmental disorder that begins in childhood or adolescence. It is characterized by multiple movement (motor) tics and at least one vocal (phonic) tic. Common tics are blinking, coughing, throat clearing, sniffing, and facial movements. These are typically preceded by an unwanted urge or sensation in the affected muscles known as a premonitory urge, can sometimes be suppressed temporarily, and characteristically change in location, strength, and frequency. Tourette's is at the more severe end of a spectrum of tic disorders. The tics often go unnoticed by casual observers.

<span class="mw-page-title-main">Coprolalia</span> Involuntary utterance of socially inappropriate words

Coprolalia is involuntary swearing or the involuntary utterance of obscene words or socially inappropriate and derogatory remarks. The word comes from the Greek κόπρος, meaning "dung, feces", and λαλιά "speech", from λαλεῖν "to talk".

Neuropsychiatry is a branch of medicine that deals with psychiatry as it relates to neurology, in an effort to understand and attribute behavior to the interaction of neurobiology and social psychology factors. Within neuropsychiatry, the mind is considered "as an emergent property of the brain", whereas other behavioral and neurological specialties might consider the two as separate entities. Those disciplines are typically practiced separately.

Neurodevelopmental disorders are a group of conditions that begin to emerge during childhood. According to the American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5) published in 2013, these conditions generally appear in early childhood, usually before children start school, and can persist into adulthood. The key characteristic of all these disorders is that they negatively impact a person's functioning in one or more domains of life depending on the disorder and deficits it has caused. All of these disorders and their levels of impairment exist on a spectrum, and affected individuals can experience varying degrees of symptoms and deficits, despite having the same diagnosis.

Societal and cultural aspects of Tourette syndrome include legal advocacy and health insurance issues, awareness of notable individuals with Tourette syndrome, and treatment of TS in the media and popular culture.

Tourette syndrome is an inherited neurodevelopmental disorder that begins in childhood or adolescence, characterized by the presence of motor and phonic tics. The management of Tourette syndrome has the goal of managing symptoms to achieve optimum functioning, rather than eliminating symptoms; not all persons with Tourette's require treatment, and there is no cure or universally effective medication. Explanation and reassurance alone are often sufficient treatment; education is an important part of any treatment plan.

Causes and origins of Tourette syndrome have not been fully elucidated. Tourette syndrome is an inherited neurodevelopmental disorder that begins in childhood or adolescence, characterized by the presence of multiple motor tics and at least one phonic tic, which characteristically wax and wane. Tourette's syndrome occurs along a spectrum of tic disorders, which includes transient tics and chronic tics.

The Tourette Association of America (TAA), based in Bayside, New York, United States, is a non-profit voluntary organization and the only US health-related organization serving people with Tourette syndrome. It was founded in 1972 as the Tourette Syndrome Association (TSA), later changing its name.

<span class="mw-page-title-main">History of Tourette syndrome</span>

Tourette syndrome is an inherited neurological disorder that begins in childhood or adolescence, characterized by the presence of multiple physical (motor) tics and at least one vocal (phonic) tic.

<span class="mw-page-title-main">GLUT1 deficiency</span> Medical condition


GLUT1 deficiency syndrome, also known as GLUT1-DS, De Vivo disease or Glucose transporter type 1 deficiency syndrome, is an autosomal dominant genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier. Glucose Transporter Type 1 Deficiency Syndrome has an estimated birth incidence of 1 in 90,000 to 1 in 24,300. This birth incidence translates to an estimated prevalence of 3,000 to 7,000 in the U.S.

Kenneth Blum is an American scientist who has studied neuropsychopharmacology and genetics. Until 1995 he was a professor of pharmacology at the University of Texas Health Science Center at San Antonio.

<i>The Gene Bomb</i>

The Gene Bomb is a 1996 book by David E. Comings, self-published by Hope Press, that puts forth the theory that higher education and advanced technology may unintentionally favor the selection of genes that increase the likelihood of ADHD, autism, drug addiction, learning disorders, and behavior problems. Comings claims that the prevalence of these disorders is rising and I.Q. is decreasing; others argue that other factors may be responsible, including increased detection of these disorders. He claims that society is inadvertently creating delays for the highly educated that reduce their reproductivity and causes them to have children later in life, thus raising the odds of certain disorders like autism. On the other hand, he claims that those having learning disorders tend to drop out of school earlier and have more children, thus passing on learning disorders at a higher rate. Environmental and societal factors are usually accepted as the cause, but Comings argues the opposite.

<span class="mw-page-title-main">Jay Tischfield</span>

Jay Tischfield is MacMillan Distinguished Professor and the Founding Chair of the Department of Genetics at Rutgers University. He is also Professor of Pediatrics and Psychiatry at Rutgers. He is currently Director of the Human Genetics Institute of New Jersey.

<span class="mw-page-title-main">Ecopipam</span> Investigational dopamine antagonist

Ecopipam is a dopamine antagonist which is under development for the treatment of Lesch-Nyhan syndrome, Tourette's syndrome, speech disorders, and restless legs syndrome. It is taken by mouth.

<span class="mw-page-title-main">Huda Zoghbi</span> Lebanese scientist

Huda Yahya Zoghbi, born Huda El-Hibri, is a Lebanese-born American geneticist, and a professor at the Departments of Molecular and Human Genetics, Neuroscience and Neurology at the Baylor College of Medicine. She is the director of the Jan and Dan Duncan Neurological Research Institute. She became the editor of the Annual Review of Neuroscience as of 2018.

<span class="mw-page-title-main">John M. Opitz</span> German-American geneticist (1935–2023)

John M. Opitz was a German-American medical geneticist and professor at the University of Utah School of Medicine. He is best known for rediscovering the concept of the developmental field in humans and for his detection and delineation of many genetic syndromes, several now known as the "Opitz syndromes" including Smith–Lemli–Opitz syndrome (SLOS), Opitz–Kaveggia syndrome (FGS1), Opitz G/BBB syndrome, Bohring–Opitz syndrome, and other autosomal and X-linked conditions. He is founder of the Wisconsin Clinical Genetics Center, the American Journal of Medical Genetics, and was a cofounder of the American College and American Board of Medical Genetics.

John Piacentini, PhD, ABPP, is an American clinical child and adolescent psychologist, and professor of psychiatry and biobehavioral sciences at the David Geffen School of Medicine at UCLA in Los Angeles, California. He is the director of the Center for Child Anxiety, Resilience, Education and Support (CARES), and the Child OCD, Anxiety and Tic Disorders Program at UCLA's Semel Institute for Neuroscience and Human Behavior.

Wendy K. Chung is an American clinical and molecular geneticist and physician. She is the Chair of the Department of Pediatrics at Boston Children's Hospital and is on the faculty at Harvard Medical School. She is the author of 700 peer-reviewed articles and 75 chapters and has won several awards as a physician, researcher, and professor. Chung helped to initiate a new form of newborn screening for spinal muscular atrophy which is used nationally and was among the plaintiffs in the Supreme Court case which banned gene patenting.

Richard J. Rose is an American psychologist and behavioral geneticist. He is Emeritus Professor of Psychological & Brain Sciences at Indiana University Bloomington and of Medical & Molecular Genetics at the Indiana University School of Medicine. He is also a visiting professor at the University of Helsinki in Finland. He received his Ph.D. from the University of Minnesota in 1964, where he was advised by David T. Lykken. A founding member of the Behavior Genetics Association, he served as its president in 1999 and received its Dobzhansky Award in 2007. He is known for his research using twins to study human behavioral traits such as alcoholism and IQ. This included working as a consultant on the Minnesota Study of Twins Reared Apart in the 1970s. He began collaborating with scientists at the University of Helsinki in 1984, and received an honorary doctorate from this university in 2009.

Michael S. Okun is an American neurologist, neuroscientist and author. He is the co-founder and director of the Norman Fixel Institute for Neurological Diseases at University of Florida Health and is also the chair of the Department of Neurology at the University of Florida and the Medical Director/Advisor for the Parkinson's Foundation. He is the fifth person at the University's College of Medicine to hold the rank of Distinguished Professor.

References

  1. "Dr. David Comings Bio". The Comings Foundation. Retrieved 2019-01-07.
  2. "Comings, David E." Library of Congress Name Authority File. Library of Congress . Retrieved 2019-01-07.
  3. 1 2 3 "Issue". The American Journal of Human Genetics . 2015-04-02.
  4. "David E. Comings 1935-". Oxford Dictionary of Scientific Quotations. Oxford University Press. 2006. ISBN   978-0-19-861443-2 . Retrieved 2017-12-15.
  5. 1 2 Gorner, Peter (1989-01-15). "Tourette Theory In Hot Dispute". Chicago Tribune . Retrieved 2017-12-15.
  6. "David Comings". American Society for Clinical Investigation . Retrieved 2017-12-15.
  7. Horacek, H. Joseph (1998). Brainstorms: Understanding and Treating the Emotional Storms of Attention Deficit Hyperactivity Disorder from Childhood Through Adulthood. Jason Aronson. p. 30. ISBN   978-0-7657-0080-3.
  8. Noble, Holcomb B. (1999-03-02). "New From the Smoking Wars: Success". The New York Times . ISSN   0362-4331 . Retrieved 2017-12-15.
  9. SCOTT, JANNY (1991-10-02). "Study Supports Genetic Link to Alcoholism". Los Angeles Times . ISSN   0458-3035 . Retrieved 2017-12-15.